About Mitochondria Report

Mitochondria Report is an independent consumer research property focused on decision-stage Urolithin A, mitophagy and mitochondrial-health supplement questions. We separate product specifications, manufacturer claims and human evidence rather than blending them into one convenient sales paragraph.

Commercial links may create a benefit for the site owner; that relationship is disclosed and does not change our requirement to distinguish verified information from marketing claims.

What MitochondriaReport is for

MitochondriaReport is a decision-stage research site focused on Urolithin A, Mitopure, mitophagy, mitochondrial-health supplements, comparisons, and commercial product evidence.

Why the site is focused

The site keeps its topical ownership centered on Urolithin A and mitochondrial quality rather than drifting into every longevity ingredient. That reduces overlap with separate senolytic and broad longevity-stack properties.

How Phase 2 changed the site

Phase 2 introduced a source-backed product database and methodology so product pages could reference actual market data.

How Phase 3 changed the site

Phase 3 expands the dataset and adds separate Value, Testing Transparency, Evidence Match, Transparency, and Stack Complexity metrics.

What the scores do not mean

None of the scores predicts whether a product will improve a specific person's health, performance, or lifespan. They are editorial comparison tools.

Editorial standards

The site separates manufacturer claims from independent research, ingredient evidence from finished-product evidence, and mechanism from proven human outcomes.

Commercial relationships

The site may link to ReCellence and other products. Commercial relationships do not justify fabricated data, hidden uncertainty, or selective interpretation.

Corrections and updates

Product facts change. Corrections are evaluated using current sources, and database records should be updated when formulas, prices, certifications, or testing documents change.

Update trigger 1

For About Mitochondria Report, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 2

For About Mitochondria Report, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 3

For About Mitochondria Report, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 4

For About Mitochondria Report, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 5

For About Mitochondria Report, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 6

For About Mitochondria Report, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 7

For About Mitochondria Report, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 8

For About Mitochondria Report, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 9

For About Mitochondria Report, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 10

For About Mitochondria Report, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 11

For About Mitochondria Report, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 12

For About Mitochondria Report, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 13

For About Mitochondria Report, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 14

For About Mitochondria Report, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.

Update trigger 15

For About Mitochondria Report, the conclusion should remain open to revision. New human trials, product reformulations, new COAs, certification changes, updated prices, and newly disclosed testing can all alter the commercial comparison. The goal is not to manufacture a permanent winner, but to show the evidence and product facts clearly enough that a reader can see why the conclusion was reached.